Generated July 8, 2026 at 8:31 PM ET
· Covers July 8 trading day
· 10 of 149 ready 8-Ks selected
· AI-assisted overview
The day's highest-materiality filings centered on major M&A and regulatory events. Vistance Networks (VISN) completed its $1.846B sale of RUCKUS to Belden, while Presidio Production (FTW) closed an $83M Canyon Creek acquisition and Tarsus Pharmaceuticals (TARS) acquired iRenix Medical for $75M upfront. On the regulatory side, Borealis Foods (BRLS) received a Nasdaq delisting notice for low MVLS, but Fusemachines (FUSE) and Upland Software (UPLD) regained compliance. Charles & Colvard completed a $2.7M asset sale in Chapter 11, and FutureTech II Acquisition Corp. restated multiple financials due to material weaknesses. Additionally, Cantor Equity Partners I (CEPO) and BSTR abandoned their current deal terms, postponing their shareholder meeting indefinitely.
regulatory
negative
materiality 0.75
July 8, 2026, 4:15 PM ET
Borealis Foods receives Nasdaq delisting notice for MVLS below $35M
- Received Nasdaq notice on July 2, 2026 for failing minimum $35M MVLS over 30 consecutive business days.
- Also fails alternative listing standards under Nasdaq Rules 5550(b)(1) and 5550(b)(3).
- Has 180-day compliance period until December 29, 2026 to regain compliance.
VISN
Vistance Networks, Inc.
M&A
positive
materiality 1.00
July 8, 2026, 5:08 PM ET
Vistance Networks completes $1.846B sale of RUCKUS to Belden; pro forma financials filed
- Sale closed July 1, 2026; cash consideration $1.846B from Belden Inc.
- Pro forma continuing ops revenue $298.4M for Q1 2026 vs $471.8M historical.
- Company expects to distribute significant portion of net proceeds to shareholders within 60 days.
FTW
PRESIDIO PRODUCTION Co
M&A
positive
materiality 0.75
July 8, 2026, 4:38 PM ET
Presidio closes $83M Canyon Creek acquisition; expects dividend increase to $1.50/share
- Purchase price ~$83M; net PDP production ~21 MMcfe/d from 55 wells; estimated PDP PV-10 ~$100M.
- Funded via first $55M draw on new $1.0B ABS Warehouse Facility led by Goldman Sachs; Citizens Bank joined with 40% participation.
- Issued 1,962,240 shares of Class A common stock to sellers; entered Registration Rights Agreement.
TARS
Tarsus Pharmaceuticals, Inc.
M&A
positive
materiality 0.75
July 8, 2026, 4:13 PM ET
Tarsus acquires iRenix Medical for ~$75M upfront; adds late-stage ocular antiseptic IRX-101
- Upfront consideration of $75M: $37.5M cash + $37.5M in Tarsus common stock (607,093 shares).
- Potential approval/commercial milestones up to $490M plus low-to-mid single-digit revenue sharing.
- IRX-101 Phase 2b/3 RELIEF trial: ~50% relative reduction in post-procedural pain (p=0.0003) vs povidone-iodine.
PRME
Prime Medicine, Inc.
litigation
positive
materiality 0.80
July 8, 2026, 8:02 AM ET
Prime Medicine wins arbitration against Beam; PM647 for AATD confirmed within Prime's field
- Arbitration tribunal ruled PM647 (AATD candidate) is within Prime's 'Field' under 2019 Collaboration Agreement with Beam.
- Tribunal denied Beam's claims for damages and injunctive relief; Prime did not breach agreement.
- Remaining claims from both parties were denied.
—
CHARLES & COLVARD LTD
other material
negative
materiality 1.00
July 8, 2026, 5:18 PM ET
Charles & Colvard completes asset sale to AJS Creations for $2.7M in Chapter 11
- Bankruptcy court approved sale of substantially all assets to AJS Creations, Inc. for $2.7M cash on July 1, 2026.
- Prior stalking horse bidder JDP terminated; break-up fee of $45,000 paid.
- Company cautions common stock may be worthless; trading highly speculative.
regulatory
positive
materiality 0.55
July 8, 2026, 8:40 AM ET
Fusemachines regains Nasdaq compliance for minimum market value of publicly held shares
- Received Nasdaq letter on July 7, 2026 confirming compliance with Listing Rule 5450(b)(1)(C).
- Minimum market value of publicly held shares requirement of $15M has been met; matter closed.
- Common stock will continue to be listed on the Nasdaq Global Market.
UPLD
Upland Software, Inc.
regulatory
positive
materiality 0.50
July 8, 2026, 9:07 AM ET
Upland Software regains Nasdaq minimum bid price compliance after 10-day closing bid above $1.00
- Received Nasdaq letter on July 2, 2026 confirming compliance with minimum bid price rule.
- Common stock closing bid price at or above $1.00 for 10 consecutive business days (June 17–July 1, 2026).
- Regained compliance with Nasdaq Listing Rule 5450(a)(1) for continued listing on The Nasdaq Global Market.
—
FutureTech II Acquisition Corp.
other material
negative
materiality 0.85
July 8, 2026, 4:30 PM ET
FutureTech II Acquisition Corp. restates multiple financial statements; material weakness identified
- Restatement covers Q3 2024, FY 2024, Q1 2025, and Q2 2025 financials due to errors in EPS, redemption, tax, and sponsor amounts.
- Board concludes previously issued financial statements and periodic reports should no longer be relied upon.
- Material weakness in internal control over financial reporting: ineffective reconciliations, inaccurate journal entries, lack of review.
CEPO
Cantor Equity Partners I, Inc.
other material
negative
materiality 0.85
July 8, 2026, 11:23 AM ET
Cantor Equity Partners I and BSTR abandon current deal terms; shareholder meeting postponed indefinitely
- CEPO and BSTR will not complete business combination on terms from July 16, 2025 agreement; discussing revised structure.
- Extraordinary general meeting of CEPO shareholders scheduled for July 10, 2026 is indefinitely postponed.
- Any CEPO public shares submitted for redemption will be returned to shareholders and will not be redeemed.